Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer

NCT03940092 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT03940092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03940092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
August 13, 2020
Completion date
December 31, 2025
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer